Boston scientific received information that this cardiac resynchronization therapy defibrillator (crt-d) was part of a system revision due to infection and erosion.Reportedly, the patient had a small hole and drainage was coming out.During the pocket revision, the physician barely opened the device pocket and did not think the device pocket needed revising.Moreover, the physician just closed the device pocket and gave the patient some antibiotics.There were no additional adverse patient effects reported.The crt-d remains in service.
|